Compare Ionis Pharmaceuticals Inc. Common Stock (IONS) vs Sprott Uranium Miners ETF (URNM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ionis Pharmaceuticals Inc. Common Stock vs Sprott Uranium Miners ETF — how do they compare? Ionis Pharmaceuticals Inc. Common Stock trades at $44.1 (market cap $7.10B), while Sprott Uranium Miners ETF trades at $41.88 (market cap $1.73B). The key difference: Ionis Pharmaceuticals Inc. Common Stock is far larger — about 4.1× Sprott Uranium Miners ETF's market cap, and Ionis Pharmaceuticals Inc. Common Stock is more actively traded (2,027,457 versus 1,087,852). Which is the better fit depends on your goals — on Pluang, investors hold Ionis Pharmaceuticals Inc. Common Stock for 0 Days and Sprott Uranium Miners ETF for 62 Days on average.
| IONS | URNM | |
|---|---|---|
Market Cap | $7.10B | $1.73B |
Volume | 2,027,457 | 1,087,852 |
Sector | Health | Commodities - Metals/Agriculture |
52-Week High | $86.50 | $83.99 |
52-Week Low | $42.38 | $42.42 |
Typical Hold Time | 0 Days | 62 Days |
Enterprise Value | $6.66B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
URNM (Sprott Uranium Miners ETF) trades at $44.51, down 1.44% today amid bearish technical signals. The ETF faces selling pressure with all 13 moving averages indicating bearish momentum. Recent news highlights uranium's strong fundamentals, with spot prices rising 21.25% over the past year according to Sprott Asset Management (ETF Trends, September 16, 2026). The fund provides concentrated exposure to uranium miners tracking the VettaFi Global Uranium Mining Index.
Long-term outlook remains positive due to nuclear energy expansion and AI power demand, but near-term technical weakness suggests caution. Key risks include uranium price volatility and regulatory uncertainty, while catalysts include government nuclear investments and growing electricity demands from data centers.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Ionis Pharmaceuticals Inc. Common Stock
Ionis Pharmaceuticals Inc. is a biopharmaceutical company that develops RNA-targeted medicines using its antisense technology, with marketed treatments in neurology and cardiometabolic disease.
Read more on IONS →About Sprott Uranium Miners ETF
URNM is a pure-play ETF that invests in the global uranium industry. It provides exposure to companies involved in the mining, exploration, and production of uranium, as well as physical uranium holdings, with top assets like Cameco, Uranium Energy Corp, and the Sprott Physical Uranium Trust.
Read more on URNM →
